BĂ–LĂœM 5 Kaynaklar Angelucci E, Brittenham GM, McLaren CE, et al Hepatic iron concentration and total body iron stores in. thalassaemia major. New Engl J Med 2000;343:327-31. Angelucci E, Muretto P, Nicolucci A, et al. Effects of iron overload and hepatitis C virus positivity in determining progression of liver fibrosis in thalassemia following bone marrow transplantation. Blood 2002;100:17-21. Azarkeivan A, Toosi MN, Maghsudlu M, et al. The incidence of hepatitis C in patients with thalassaemia after screening in blood transfusion centers: a fourteen-year study. Transfusion 2012;52:1814-8. Berdoukas V, Farmaki K, Carson S, et al. Treating thalassemia major-related iron overload: the role of deferiprone. J Blood Med 2012;3:119-29. Brissot P, Bardou-Jacquet E, Jouanolle AM, et al. Iron disorders of genetic origin: a changing world. Trends Mol Med 2011;17:707-13. Brissot P, Ropert M, Le Lan C, et al. Non-transferrin bound iron: A key role in iron overload and iron toxicity. Biochim Biophys Acta 2012;1820:403-10. Deugnier Y, Turlin B. Pathology of hepatic iron overload. Semin Liver Dis 2011;31:260-71. Deugnier Y, Turlin B, Ropert M, et al. Improvement in liver pathology of patients with beta-thalassemia treated with deferasirox for at least 3 years. Gastroenterology 2011;141:1202-11 Di Marco V, Bronte F, Calvaruso V, et al. IL28B polymorphisms influence stage of fibrosis and spontaneous or interferon-induced viral clearance in thalassemia patients with hepatitis C virus infection. Haematologica 2012;97:679-86. Di Marco V, Capra M, Angelucci E, et al. Management of chronic viral hepatitis in patients with thalassemia: recommendations from an international panel. Blood 2010;116:2875-83. El-Shabrawi MH, Zein El Abedin MY, Omar N, et al. Predictive accuracy of serum hyaluronic acid as a noninvasive marker of fibrosis in a cohort of multi-transfused Egyptian children with beta-thalassaemia major. Arab J Gastroenterol 2012;13:45-8. Elalfy MS, Esmat G, Matter RM, et al. Liver fibrosis in young Egyptian beta-thalassemia major patients: relation to hepatitis C virus and compliance with chelation. Ann Hepatol 2012;12:54-61. Elborai Y, Uwumugambi A, Lehmann L. Hematopoietic stem cell transplantation for thalassemia. Immunotherapy 2012;4:947-56.
Esposito BP, Breuer W, Sirankapracha P, et al Labile plasma iron in iron overload: redox activity and. susceptibility to chelation. Blood 2003;102:2670-7. Ganz T, Nemeth E. Hepcidin and iron homeostasis. Biochim Biophys Acta 2012;1823:1434-43. Guo S, Casu C, Gardenghi S, et al. Reducing TMPRSS6 ameliorates hemochromatosis and beta-thalassemia in mice. J Clin Invest 2013;123:1531-41. Hershko C. Pathogenesis and management of iron toxicity in thalassemia. Ann N Y Acad Sci 2010;1202:1-9. Hoffbrand AV, Taher A, Cappellini MD. How I treat transfusional iron overload. Blood 2012;120:3657-69. Jensen PD, Jensen FT, Christensen T, et al. Relationship between hepatocellular injury and transfusional iron overload prior to and during iron chelation with desferrioxamine: a study in adult patients with acquired anemias. Blood 2003;101:91-6. Khalil A, Zaidman I, Elhasid R, et al. Factors influencing outcome and incidence of late complications in children who underwent allogeneic hematopoietic stem cell transplantation for hemoglobinopathy. Pediatr Hematol and Oncol 2012;29:694-703. Kolnagou A, Natsiopoulos K, Kleanthous M, et al. Liver iron and serum ferritin levels are misleading for estimating cardiac, pancreatic, splenic and total body iron load in thalassemia patients: factors influencing the heterogenic distribution of excess storage iron in organs as identified by MRI T2*. Toxicol Mech Methods 2013;23:48-56. Lai ME, Origa R, Danjou F, et al. Natural history of hepatitis C in thalassemia major: a long-term prospective study. Eur J Haematol 2013;90:501-7. Lal A, Porter J, Sweeters N, et al. Combined chelation therapy with deferasirox and deferoxamine in thalassemia. Blood Cells Mol Dis 2013;50:99-104. Li CK, Chik KW, Lam CW, et al. Liver disease in transfusion dependent thalassaemia major. Arch Dis Child 2002;86:344-7. Lobo C, Angulo IL, Aparicio LR, et al. Retrospective epidemiological study of Latin American patients with transfusional hemosiderosis: the first Latin American epidemiological study in iron overload--the RELATH study. Hematology 2011;16:265-73. Maakaron JE, Cappellini MD, Graziadei G, et al. Hepatocellular carcinoma in hepatitis-negative patients with thalassemia intermedia: a closer look at the role of siderosis. Ann Hepatol 2013;12:142-6.
131